United States · FDA National Drug Code directory
Loratadine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-818_cfa8d72c-3d1a-464c-b63a-b7b7525c1a3c
- Product NDC
- 58602-818
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- Loratadine
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230324
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 BLISTER PACK in 1 CARTON (58602-818-05) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · 58602-818-05
- 4 BLISTER PACK in 1 CARTON (58602-818-08) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · 58602-818-08
- 2 BLISTER PACK in 1 CARTON (58602-818-67) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · 58602-818-67
- 1 BLISTER PACK in 1 CARTON (58602-818-83) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · 58602-818-83
- 3 BLISTER PACK in 1 CARTON (58602-818-84) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · 58602-818-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →